Type 2 & other diabetes

Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention

Cardiovasc DiabetolPublished Cohort study

Authors' conclusion

The findings highlight the potential of the TyG index as a predictor of recurrent revascularization. Lesion progression emerged as the primary contributor to recurrent revascularization instead of in-stent restenosis. The incorporation of the TyG index into risk prediction models is likely to be beneficial for accurate risk stratification in order to improve prognosis.

Study context

Population
Patients with T2DM after percutaneous coronary intervention (PCI)
Participants
633 patients
Exposure
Triglyceride-glucose (TyG) index tertiles
Outcome
Recurrent revascularization resulting from progression of lesions or in-stent restenosis (ISR); all-cause death as competing risk
Follow-up
Median 18.33 months
Methodological detailscompeting risk analysis, internal bootstrap validation (1000 resamples)
  • Competing risk analysis
  • Internal bootstrap validation (1000 resamples)

Main finding

As reported in the abstract

Recurrent revascularization

Patients with recurrent revascularization

64

10.11%

Lesion progression cases

55

In-stent restenosis cases

9

TyG index (standardized) subdistribution hazard ratio (SHR) for recurrent revascularization, after controlling for competing risk; 95% CI 1.1458-1.7959; P = 0.002

1.4345

Observational data: associations, not effects.

Further findings

Incremental predictive value of TyG index added to established risk model

C-index
0.759 (95% CI 0.724-0.792, P < 0.01)
cNRI > 0
0.170 (95% CI 0.023-0.287, P < 0.05)
Integrated discrimination improvement (IDI)
0.024 (95% CI 0.009-0.039, P = 0.002)
Likelihood ratio test and Akaike's information criteria: TyG index significantly improves prognostic ability
Results consistent on internal bootstrap validation

Original publication

Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention. Cardiovasc Diabetol. Published 21 October 2023. doi:10.1186/s12933-023-02011-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.